is a glp-1 a peptide Glucagon-like 1 (7-37) Glucagon-Like Peptide 1, GLP-1 (7-36),

This effect decreases appetite, which lessens food consumption

The most common retatrutide side effects The most common side effects of retatrutide are gastrointestinal-related and tend to be mild and temporary, which subside on their own or with lifestyle changes

Future Research Directions Future research should focus on identifying which patients have clinically meaningful retained gastric contents and which mitigation strategies reduce risk without causing unnecessary cancellations or metabolic harm

Retatrutide has not received marketing authorisation from the MHRA or EMA and is only available within regulated clinical trials

World J Diabetes

Stimulant-Conscious Formula Designed to support metabolism and appetite control without harsh stimulant effects